» Articles » PMID: 28425167

Continuous Subcutaneous Insulin Infusion: Special Needs for Children

Overview
Publisher Wiley
Date 2017 Apr 21
PMID 28425167
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Continuous subcutaneous insulin infusion (CSII) is a very common therapy for children with type 1 diabetes. Due to physiological differences they have other requirements for their insulin pump than adults. The main difference is the need for very low basal rates. Even though most available insulin pumps reach a high accuracy at usual basal rates, accuracy decreases for lower rates. In addition, the lowest delivered amount at 1 time is limiting the fine tuning of the basal rate as well as the option for temporary basal rates. Alarms in case of occlusions depend on accumulation of a certain amount of insulin in the catheter, and therefore the time until such an alarm is triggered is much longer with lower basal rates. Accordingly, the risk for hyperglycemia developing into diabetic ketoacidosis increases. The availability of bolus advisors facilitates the calculation of meal and correction boluses for children and their parents. However, there are some differences between the calculators, and the settings that the calculation is based on are very important. Better connectivity, for example with a system for continuous glucose monitoring, might help to further increase safety in the use of CSII in children. When selecting an insulin pump for a child, the features and characteristics of available pumps should be properly compared to ensure an effective and safe therapy.

Citing Articles

International Society for Pediatric and Adolescent Diabetes Clinical Practice Consensus Guidelines 2024: Diabetes Technologies - Insulin Delivery.

Biester T, Berget C, Boughton C, Cudizio L, Ekhlaspour L, Hilliard M Horm Res Paediatr. 2024; 97(6):636-662.

PMID: 39657603 PMC: 11854989. DOI: 10.1159/000543034.


The Artificial Pancreas and Type 1 Diabetes.

Nwokolo M, Hovorka R J Clin Endocrinol Metab. 2023; 108(7):1614-1623.

PMID: 36734145 PMC: 10271231. DOI: 10.1210/clinem/dgad068.


One-Year Real-World Study on Comparison among Different Continuous Subcutaneous Insulin Infusion Devices for the Management of Pediatric Patients with Type 1 Diabetes: The Supremacy of Hybrid Closed-Loop Systems.

Bombaci B, Passanisi S, Alibrandi A, DArrigo G, Patroniti S, Averna S Int J Environ Res Public Health. 2022; 19(16).

PMID: 36011925 PMC: 9408433. DOI: 10.3390/ijerph191610293.


Use of continuous subcutaneous insulin infusion in children and adolescents with type 1 diabetes mellitus: a systematic mapping review.

Alvarenga C, La Banca R, Neris R, Sparapani V, Fuentealba-Torres M, Cartagena-Ramos D BMC Endocr Disord. 2022; 22(1):43.

PMID: 35183150 PMC: 8858488. DOI: 10.1186/s12902-022-00950-7.


High Frequency of Dermatological Complications in Children and Adolescents with Type 1 Diabetes: A Web-Based Survey.

Lombardo F, Passanisi S, Tinti D, Messina M, Salzano G, Rabbone I J Diabetes Sci Technol. 2020; 15(6):1377-1381.

PMID: 32757778 PMC: 8655296. DOI: 10.1177/1932296820947072.